肾病和泌尿外科是用于研究肾脏以及泌尿系统的术语。这些也在推荐与他们相关的各种并发症和疾病的同时使用。该医学科学的分支使用肾病和泌尿外科器件来获得对这些人体的这些中央系统的更好感。根据世界卫生组织(世卫组织),200多万人患有与前列腺相关的疾病,如腺体炎症,导致尿液通过身体流动的堵塞和收缩。此外,根据同一份报告,大约1.9亿患者患有慢性肾功能衰竭并进行肾透析。这种疾病的患病率吸引了专家对使用前瞻性肾脏和泌尿外科的泌尿外科,这显着降低了恢复时间和治疗成本。
Nephrology and urology devices are medical devices that are used for the treatment of urinary system and kidney diseases such as end-stage renal disease (ESRD), kidney stone, chronic kidney diseases (CKD), urinary incontinence, benign prostatic hyperplasia (BPH) and pelvic organ prolapse.
The global nephrology and urology device market is driven by factors such as rising number of cases of chronic kidney and urinary tract diseases. According to the ‘United States National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)’ reports, more than 2 million kidney stone patients are diagnosed every year in the U.S. Such high amount of patients eventually requiring treatments is expected to be major driving factor for the market growth. Innovation in urology and nephrology devices and an increase in healthcare expenses are also factors positively impacting the global market growth. Furthermore, increasing awareness of the advantages associated with these devices such as reduced recovery time and treatment cost is also boosting the overall market. The rising number of cases among growing geriatric population is accountable for this evolution in the market.
However, the high cost associated with these devices might hinder the growth of this market. Moreover, limited awareness in lower income regions also hampers the market growth.
The global Nephrology and Urology Device market is segmented on the basis of device and geography.
On the basis of Device, this market is segmented into:
Geographically, the global Nephrology and Urology Device market is segmented into North America, Europe, Asia pacific, Latin America, Middle East, and Africa.
In terms of geography, the global regional nephrology and urology devices market is currently dominated by Europe. Europe accounted to hold a share more than 40% in the regional nephrology and urology devices market. The major growth in this region is primarily due to the presence of key market players executing extensive growth strategies. In addition, research and development (R&D) investments by the government are also anticipated to be the growth factor responsible for the major market share in this region. Furthermore, increasing of patient pool requiring advanced technological treatment is anticipated to widen the base for growth.
The Asia Pacific market is anticipated to dominate the global market in the upcoming years. The high intensity of R&D, as well as the growing awareness in the emerging economies, such as Japan, China, and India, are factors enhancing the market growth in this region. In addition, growing popularity of medical tourism is also anticipated to significantly enhance the market with lucrative growth opportunities.
Key players in the global Nephrology and Urology Device Market:
产品发布,合并和收购以及研发是这些参与者通过的战略举措,以加强其在市场上的全球业务。例如,2013年9月,Baxter收购了医疗器械公司的Gambro。此次收购扩大了百乐仪的透析产品组合及其在透析业务中的地理存在。